Zai Lab Limited operates as a bio-pharmaceutical company. The Company researches and develops therapeutic technology for antibody-based oncology, autoimmune, and infectious diseases treatments. Zai Lab also manufactures drugs in the form of capsules, injections, and liquids. Zai Lab serves patients worldwide.

Current Report (Form 8-K | Period ending 2024-11-14)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Zai Lab Ltd (ZLAB US)

Current Report (Form 8-K | Period ending 2024-11-14)

424B5 | Prospectus

424B5 | Prospectus

Current Report (Form 8-K | Period ending 2024-11-13)

Quarterly Report (Form 10-Q | Period ending 2024-09-30)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)